Symetis

Symetis

Symetis

Symetis is a Swiss company developing minimally invasive heart valve replacement therapies for patients suffering from heart valve diseases.
Raised
$25.8M
Follow us
Alexa global traffic share
Acquired by
Boston Scientific
2
30 Mar 2017
$435,000,000
Latest funding
Undisclosed amount
Venture capital (Series D) - 2012
$25,800,000
Venture capital (Series C) - 2010
$435,000,000
PE HUB , Xconomy

Boston Scientific to buy Symetis for $435 mln

Health Apps & Services